2002
DOI: 10.1046/j.1617-0830.6.s1.3.x
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear Medicine in Neurodegenerative Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 67 publications
(81 reference statements)
0
1
0
Order By: Relevance
“…SPECT imaging of dopamine transporter with 99m Tc-TRODAT-1 (TRODAT-1) has been proposed to be a valuable and feasible means for the diagnosis of Parkinson's disease and dementia with Lewy bodies (DLB) [1–5]. The specific tracer, TRODAT-1, a radiolabeled tropane that binds dopamine transporters, allows in vivo assessment of the presynaptic dopaminergic neuron activity inside the striatum [3, 6].…”
Section: Introductionmentioning
confidence: 99%
“…SPECT imaging of dopamine transporter with 99m Tc-TRODAT-1 (TRODAT-1) has been proposed to be a valuable and feasible means for the diagnosis of Parkinson's disease and dementia with Lewy bodies (DLB) [1–5]. The specific tracer, TRODAT-1, a radiolabeled tropane that binds dopamine transporters, allows in vivo assessment of the presynaptic dopaminergic neuron activity inside the striatum [3, 6].…”
Section: Introductionmentioning
confidence: 99%